Thomas Smith
Stock Analyst at Leerink Partners
(4.98)
# 67
Out of 5,090 analysts
696
Total ratings
54.6%
Success rate
47%
Average return
Main Sectors:
Stocks Rated by Thomas Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IVA Inventiva | Reiterated: Buy | $12 | $3.65 | +228.77% | 3 | Oct 29, 2026 | |
| EQ Equillium | Reiterated: Buy | $6 | $1.37 | +337.96% | 35 | Oct 27, 2026 | |
| IRON Disc Medicine | Rated: Buy | $100 → $130 | $80.84 | +60.81% | 29 | Oct 27, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,065 → $1,115 | $892.87 | +24.88% | 37 | Oct 9, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | $14 → $30 | $11.78 | +154.67% | 33 | Oct 1, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | n/a | $9.92 | - | 16 | Oct 1, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $70 → $88 | $30.10 | +192.36% | 42 | Sep 23, 2026 | |
| EVMN Evommune | Rated: Buy | $52 → $22 | $6.73 | +226.89% | 3 | Sep 10, 2026 | |
| SYRE Spyre Therapeutics | Rated: Buy | $106 → $128 | $96.56 | +32.56% | 2 | Sep 10, 2026 | |
| KROS Keros Therapeutics | Reiterated: Buy | $35 → $23 | $11.04 | +108.33% | 53 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.04 | +390.20% | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $7.17 | +429.99% | 1 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.25 | - | 8 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $3.35 | +258.21% | 1 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.49 | - | 17 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $6.73 | +375.48% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $24.67 | +102.68% | 39 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $50 | $29.17 | +71.41% | 37 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $7.49 | +380.64% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.8022 | - | 20 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $32 | $5.67 | +464.37% | 18 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 102.00 | kr 39.34 | +159.28% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $27.28 | n/a | 38 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.35 | n/a | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.97 | n/a | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $115 | $86.59 | n/a | 17 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $430.36 | n/a | 39 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.77 | n/a | 34 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.91 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $15.72 | n/a | 16 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $7.51 | n/a | 28 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $13.56 | n/a | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 | $126.63 | n/a | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.50 | n/a | 25 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $0.8589 | n/a | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.47 | n/a | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2 | $21.49 | n/a | 16 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 5,234p | 117p | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $21 | $10.44 | n/a | 1 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $6 | $1.80 | n/a | 1 | Sep 8, 2017 |
Inventiva
Oct 29, 2026
Reiterated: Buy
Price Target: $12
Current: $3.65
Upside: +228.77%
Equillium
Oct 27, 2026
Reiterated: Buy
Price Target: $6
Current: $1.37
Upside: +337.96%
Disc Medicine
Oct 27, 2026
Rated: Buy
Price Target: $100 → $130
Current: $80.84
Upside: +60.81%
argenx SE
Oct 9, 2026
Reiterated: Buy
Price Target: $1,065 → $1,115
Current: $892.87
Upside: +24.88%
MoonLake Immunotherapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $14 → $30
Current: $11.78
Upside: +154.67%
Sagimet Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.92
Upside: -
Celldex Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $70 → $88
Current: $30.10
Upside: +192.36%
Evommune
Sep 10, 2026
Rated: Buy
Price Target: $52 → $22
Current: $6.73
Upside: +226.89%
Spyre Therapeutics
Sep 10, 2026
Rated: Buy
Price Target: $106 → $128
Current: $96.56
Upside: +32.56%
Keros Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $35 → $23
Current: $11.04
Upside: +108.33%
Jul 28, 2026
Reiterated: Buy
Price Target: $10
Current: $2.04
Upside: +390.20%
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $7.17
Upside: +429.99%
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.25
Upside: -
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.35
Upside: +258.21%
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.49
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $6.73
Upside: +375.48%
Apr 6, 2026
Reiterated: Buy
Price Target: $50
Current: $24.67
Upside: +102.68%
Apr 2, 2026
Reiterated: Buy
Price Target: $52 → $50
Current: $29.17
Upside: +71.41%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $7.49
Upside: +380.64%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.8022
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $25 → $32
Current: $5.67
Upside: +464.37%
Nov 26, 2025
Initiated Coverage: Buy
Price Target: kr 102.00
Current: kr 39.34
Upside: +159.28%
Oct 23, 2025
Reiterated: Buy
Price Target: $118
Current: $27.28
Upside: n/a
Oct 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.35
Upside: n/a
Oct 15, 2025
Reiterated: Buy
Price Target: $7
Current: $3.97
Upside: n/a
Oct 8, 2025
Reiterated: Buy
Price Target: $104 → $115
Current: $86.59
Upside: n/a
Aug 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $430.36
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $8
Current: $2.77
Upside: n/a
Apr 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.91
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $58
Current: $15.72
Upside: n/a
Aug 8, 2024
Reiterated: Hold
Price Target: $5
Current: $7.51
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $6
Current: $13.56
Upside: n/a
Aug 7, 2024
Reiterated: Hold
Price Target: $33
Current: $126.63
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $7
Current: $3.50
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $46
Current: $0.8589
Upside: n/a
Mar 15, 2024
Reiterated: Buy
Price Target: n/a
Current: $29.47
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: $13 → $2
Current: $21.49
Upside: n/a
Aug 8, 2022
Reiterated: Buy
Price Target: 5,234p
Current: 117p
Upside: n/a
Jan 17, 2019
Initiated Coverage: Hold
Price Target: $21
Current: $10.44
Upside: n/a
Sep 8, 2017
Initiated Coverage: Hold
Price Target: $6
Current: $1.80
Upside: n/a